These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22001865)

  • 1. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
    Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
    Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
    Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
    J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion.
    Tsuruya K; Yokoyama K; Mishima Y; Ida K; Araki T; Ieda S; Ohtsuka M; Inagaki Y; Honda A; Kagawa T; Kamiya A
    J Lipid Res; 2024 Sep; 65(9):100616. PubMed ID: 39111549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
    Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
    J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.
    Baghdasaryan A; Fickert P; Fuchsbichler A; Silbert D; Gumhold J; Hörl G; Langner C; Moustafa T; Halilbasic E; Claudel T; Trauner M
    Liver Int; 2008 Aug; 28(7):948-58. PubMed ID: 18410282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice.
    Irungbam K; Roderfeld M; Glimm H; Hempel F; Schneider F; Hehr L; Glebe D; Churin Y; Morlock G; Yüce I; Roeb E
    Lab Invest; 2020 Nov; 100(11):1411-1424. PubMed ID: 32612285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
    Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
    Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
    Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
    J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripherally Restricted CB1 Receptor Inverse Agonist JD5037 Treatment Exacerbates Liver Injury in MDR2-Deficient Mice.
    Chen J; Li F; Lee J; Manirujjaman M; Zhang L; Song ZH; McClain C; Feng W
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
    Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
    Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB4 disease: Many faces of one gene deficiency.
    Sticova E; Jirsa M
    Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
    Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
    Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
    Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
    J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
    Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
    J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
    Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
    Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
    Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
    Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
    Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
    PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.